Usp18 deficient mammary epithelial cells create an antitumour environment driven by hypersensitivity to IFN-λ and elevated secretion of Cxcl10
出版年份 2013 全文链接
标题
Usp18 deficient mammary epithelial cells create an antitumour environment driven by hypersensitivity to IFN-λ and elevated secretion of Cxcl10
作者
关键词
-
出版物
EMBO Molecular Medicine
Volume 5, Issue 7, Pages 1035-1050
出版商
EMBO
发表日期
2013-05-16
DOI
10.1002/emmm.201201864
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Chemosensitivity is controlled by p63 modification with ubiquitin-like protein ISG15
- (2012) Young Joo Jeon et al. JOURNAL OF CLINICAL INVESTIGATION
- Usp18 Promotes Conventional CD11b+ Dendritic Cell Development
- (2012) X.-L. Cong et al. JOURNAL OF IMMUNOLOGY
- Silencing of Irf7 pathways in breast cancer cells promotes bone metastasis through immune escape
- (2012) Bradley N Bidwell et al. NATURE MEDICINE
- Natural Innate and Adaptive Immunity to Cancer
- (2011) Matthew D. Vesely et al. Annual Review of Immunology
- IL-28A (IFN-λ2) modulates lung DC function to promote Th1 immune skewing and suppress allergic airway disease
- (2011) Ourania Koltsida et al. EMBO Molecular Medicine
- CXCR3 ligands: redundant, collaborative and antagonistic functions
- (2011) Joanna R Groom et al. IMMUNOLOGY AND CELL BIOLOGY
- Two Independent Mechanisms Promote Expression of an N-terminal Truncated USP18 Isoform with Higher DeISGylation Activity in the Nucleus
- (2011) Christoph Burkart et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- USP18-Based Negative Feedback Control Is Induced by Type I and Type III Interferons and Specifically Inactivates Interferon α Response
- (2011) Véronique François-Newton et al. PLoS One
- Inflammation driven by tumour-specific Th1 cells protects against B-cell cancer
- (2011) Ole Audun Werner Haabeth et al. Nature Communications
- CD4+ T cells inhibit the neu-specific CD8+ T-cell exhaustion during the priming phase of immune responses against breast cancer
- (2010) Maciej Kmieciak et al. BREAST CANCER RESEARCH AND TREATMENT
- Integrating individual functional moieties of CXCL10 and CXCL11 into a novel chimeric chemokine leads to synergistic antitumor effects: a strategy for chemokine-based multi-target-directed cancer therapy
- (2010) Ping Wang et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Blockade of the Ubiquitin Protease UBP43 Destabilizes Transcription Factor PML/RAR and Inhibits the Growth of Acute Promyelocytic Leukemia
- (2010) Y. Guo et al. CANCER RESEARCH
- Identification of USP18 as an Important Regulator of the Susceptibility to IFN- and Drug-Induced Apoptosis
- (2010) H. Potu et al. CANCER RESEARCH
- Interferon Lambda as a Potential New Therapeutic for Hepatitis C
- (2009) Dennis M. Miller et al. Annals of the New York Academy of Sciences
- Depletion of CD4 T cells enhances immunotherapy for neuroblastoma after syngeneic HSCT but compromises development of antitumor immune memory
- (2009) W. Jing et al. BLOOD
- Induction of IP-10/CXCL10 secretion as an immunomodulatory effect of low-dose adjuvant interferon-alpha during treatment of melanoma☆
- (2009) Anne-Marie Mohty et al. IMMUNOBIOLOGY
- Impaired interferon signaling is a common immune defect in human cancer
- (2009) R. J. Critchley-Thorne et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- TNFR1 Signaling and IFN-γ Signaling Determine whether T Cells Induce Tumor Dormancy or Promote Multistage Carcinogenesis
- (2008) Nele Müller-Hermelink et al. CANCER CELL
- IFN-Lambda (IFN-λ) Is Expressed in a Tissue-Dependent Fashion and Primarily Acts on Epithelial Cells In Vivo
- (2008) Caroline Sommereyns et al. PLoS Pathogens
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started